Research programme: proline dehydrogenase inhibitors - Calithera Biosciences

Drug Profile

Research programme: proline dehydrogenase inhibitors - Calithera Biosciences

Alternative Names: Proline oxidase inhibitors - Calithera

Latest Information Update: 27 Jul 2015

Price : $50

At a glance

  • Originator Calithera Biosciences
  • Class Small molecules
  • Mechanism of Action Oxidoreductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Breast cancer

Most Recent Events

  • 22 Apr 2015 Pharmacodynamics data from a preclinical trial in Breast cancer presented at the 106th Annual Meeting of the American Association for Cancer Research (AACR-2015)
  • 22 Apr 2015 Early research in Breast cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top